These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16311705)

  • 1. [Genomic medicine: a privilege of developed countries?].
    Rothhammer F
    Rev Med Chil; 2005 Sep; 133(9):1108-10. PubMed ID: 16311705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology to improve health in developing countries -- a review.
    Acharya T; Kennedy R; Daar AS; Singer PA
    Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):341-50. PubMed ID: 15322621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Global Collaborative to Advance Genomic Medicine.
    Ginsburg GS
    Am J Hum Genet; 2019 Mar; 104(3):407-409. PubMed ID: 30849327
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic medicine and developing countries: creating a room of their own.
    Séguin B; Hardy BJ; Singer PA; Daar AS
    Nat Rev Genet; 2008 Jun; 9(6):487-93. PubMed ID: 18487990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top ten biotechnologies for improving health in developing countries.
    Daar AS; Thorsteinsdóttir H; Martin DK; Smith AC; Nast S; Singer PA
    Nat Genet; 2002 Oct; 32(2):229-32. PubMed ID: 12355081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New genetics, new ethics? Globalisation and its discontents.
    Glasner P; Rothman H
    Health Risk Soc; 2001 Nov; 3(3):245-59. PubMed ID: 15080126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics--a global public good?
    Thorsteinsdóttir H; Daar AS; Smith RD; Singer PA
    Lancet; 2003 Mar; 361(9361):891-2. PubMed ID: 12648966
    [No Abstract]   [Full Text] [Related]  

  • 10. The Human Genome Diversity Project: medical benefits versus ethical concerns.
    Wallace RW
    Mol Med Today; 1998 Feb; 4(2):59-62. PubMed ID: 9547791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying genomics-related technologies for Africa's health needs.
    Singer PA; Court EB; Bhatt A; Frew SE; Greenwood H; Persad DL; Salamanca-Buentello F; Séguin B; Taylor AD; Daer HT; Daar AS
    Afr J Med Med Sci; 2007; 36 Suppl():7-14. PubMed ID: 17703557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond a western bioethics?
    Ryan MA
    Theol Stud; 2004 Mar; 65(1):158-77. PubMed ID: 15515232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case studies on the use of biotechnologies and on biosafety provisions in four African countries.
    Black R; Fava F; Mattei N; Robert V; Seal S; Verdier V
    J Biotechnol; 2011 Dec; 156(4):370-81. PubMed ID: 21763362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing genomics and biotechnology to improve global health equity.
    Singer PA; Daar AS
    Science; 2001 Oct; 294(5540):87-9. PubMed ID: 11588248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agricultural biotechnologies in developing countries and their possible contribution to food security.
    Ruane J; Sonnino A
    J Biotechnol; 2011 Dec; 156(4):356-63. PubMed ID: 21723334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social, political, and epistemological aspects of genetics and genomics.
    Lock M; Cox S; d'Agincourt-Canning L
    Community Genet; 2006; 9(3):137-41. PubMed ID: 16741342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries.
    Salicrup LA; Fedorková L
    Biotechnol Adv; 2006; 24(1):69-79. PubMed ID: 16098701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN).
    Séguin B; Hardy BJ; Singer PA; Daar AS
    Nat Rev Genet; 2008 Oct; 9 Suppl 1():S5-9. PubMed ID: 18802419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy and ethical issues in applying medical biotechnology in developing countries.
    Bhardwaj M; Macer DR
    Med Sci Monit; 2003 Feb; 9(2):RA49-54. PubMed ID: 12601306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance.
    Cooper DN; Brand A; Dolzan V; Fortina P; Innocenti F; Michael Lee MT; Macek M; Al-Mulla F; Prainsack B; Squassina A; Vayena E; Vozikis A; Williams MS; Patrinos GP
    Per Med; 2014 Sep; 11(7):615-623. PubMed ID: 29764053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.